ARTV
Artiva Biotherapeutics
ARTV
ARTV
40 hedge funds and large institutions have $108M invested in Artiva Biotherapeutics in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.97% less ownership
Funds ownership: 69.08% → 68.11% (-0.97%)
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
Holders
40
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$724K | |
| 2 | +$152K | |
| 3 | +$124K | |
| 4 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
+$115K |
| 5 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
+$107K |
Top Sellers
| 1 | -$580K | |
| 2 | -$464K | |
| 3 | -$341K | |
| 4 |
Renaissance Technologies
New York
|
-$179K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$175K |
